Literature DB >> 26731215

Bilateral Spontaneous Hyphema, Vitreous Hemorrhage, and Choroidal Detachment With Concurrent Dabigatran Etexilate Therapy.

Kevin Wang, Justis P Ehlers.   

Abstract

A 79-year-old woman was referred for rapid onset of painless bilateral vision loss. Anterior segment exams revealed bilateral spontaneous hyphema and fibrin accumulation. Observation of the posterior chamber by B-scan ultrasound showed vitreous hemorrhage and choroidal detachment bilaterally. No evidence of additional intraocular inflammation was present. Laboratory work-up for hematologic abnormalities was unremarkable. These hemorrhagic events were suspected to be a complication from taking the novel anticoagulant, dabigatran etexilate (Pradaxa; Boehringer, Ingelheim, Germany). She initially underwent non-surgical therapy, which included immediate cessation of dabigatran, and administration of topical and systemic steroids. The lack of response to medical therapy in the left eye led to surgical treatment of vitreous and persistent subcapsular hemorrhage via pars planar vitrectomy with capsulectomy. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26731215      PMCID: PMC4915960          DOI: 10.3928/23258160-20151214-13

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  14 in total

1.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  L Samuel Wann; Anne B Curtis; Kenneth A Ellenbogen; N A Mark Estes; Michael D Ezekowitz; Warren M Jackman; Craig T January; James E Lowe; Richard L Page; David J Slotwiner; William G Stevenson; Cynthia M Tracy
Journal:  J Am Coll Cardiol       Date:  2011-02-14       Impact factor: 24.094

2.  Idarucizumab for Dabigatran Reversal.

Authors:  Charles V Pollack; Paul A Reilly; John Eikelboom; Stephan Glund; Peter Verhamme; Richard A Bernstein; Robert Dubiel; Menno V Huisman; Elaine M Hylek; Pieter W Kamphuisen; Jörg Kreuzer; Jerrold H Levy; Frank W Sellke; Joachim Stangier; Thorsten Steiner; Bushi Wang; Chak-Wah Kam; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2015-06-22       Impact factor: 91.245

3.  Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.

Authors:  Stephan Glund; Joachim Stangier; Michael Schmohl; Dietmar Gansser; Stephen Norris; Joanne van Ryn; Benjamin Lang; Steven Ramael; Viktoria Moschetti; Fredrik Gruenenfelder; Paul Reilly; Jörg Kreuzer
Journal:  Lancet       Date:  2015-06-15       Impact factor: 79.321

4.  Bilateral spontaneous hyphema with uveitis in a young girl.

Authors:  Yoshiaki Shimada; Masayuki Horiguchi; Taku Okubo
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2004 Mar-Apr       Impact factor: 1.402

5.  Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Authors:  Sam Schulman; Clive Kearon; Ajay K Kakkar; Patrick Mismetti; Sebastian Schellong; Henry Eriksson; David Baanstra; Janet Schnee; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

6.  Bilateral spontaneous hyphema in juvenile xanthogranuloma.

Authors:  P Vijayalakshmi; Shashikant Shetty; Jitendra Jethani; T B Uma Devi
Journal:  Indian J Ophthalmol       Date:  2006-03       Impact factor: 1.848

Review 7.  Bilateral spontaneous hyphaema: case report and review of literature.

Authors:  Aruna Dharmasena; Gillian M Watts
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

8.  Removal of dabigatran by hemodialysis.

Authors:  Don N Chang; William E Dager; Andrew I Chin
Journal:  Am J Kidney Dis       Date:  2012-12-05       Impact factor: 8.860

9.  Subconjunctival hemorrhage in a patient on dabigatran (Pradaxa).

Authors:  Tam M Nguyen; Michael P Phelan; Xiang Q Werdich; Paul J Rychwalski; Christopher M Huff
Journal:  Am J Emerg Med       Date:  2012-09-20       Impact factor: 2.469

10.  Bilateral spontaneous hyphema arising from iridic microhemangiomas.

Authors:  G I Mason; A P Ferry
Journal:  Ann Ophthalmol       Date:  1979-01
View more
  5 in total

1.  Risk of intraocular hemorrhage with new oral anticoagulants.

Authors:  G Talany; M Guo; M Etminan
Journal:  Eye (Lond)       Date:  2016-12-23       Impact factor: 3.775

2.  Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).

Authors:  Irina S Barequet; Tzukit Zehavi-Dorin; Nirit Bourla; Ilia Tamarin; Joseph Moisseiev; Ophira Salomon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-22       Impact factor: 3.117

3.  Association of Novel Oral Antithrombotics With the Risk of Intraocular Bleeding.

Authors:  Katherine E Uyhazi; Todd Miano; Wei Pan; Brian L VanderBeek
Journal:  JAMA Ophthalmol       Date:  2018-02-01       Impact factor: 7.389

4.  Spontaneous hyphema in the setting of COVID-19 pneumonia.

Authors:  Joey Chiang; Lawrence Chan; Jeannette Y Stallworth; Matilda F Chan
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-18

5.  Intraocular Hemorrhage due to use of Sildenafil in a Patient with Diabetes.

Authors:  Cagri Ilhan; Mehmet Murat Uzel; Mehmet Citirik
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.